Added Pressure Ulcers chapter
Minor revision to clarify validated clinical stability criteria to discontinue therapy after 3 or 5 days of therapy.
Revised Pediatric Guidelines
Aligns with Regional Pre-Printed Orders for Peritoneal Dialysis (PD) Peritonitis Management [DRDO107472]
Updated dosing for certain IV antimicrobials
A commentary with detailed description of changes can be found within that section.
Content is now divided into 4 sections:
Aligns with Regional Pre-Printed Orders for Sepsis (Suspected) - Initial Management: Obstetrics [DRDO106138B]
Revised amikacin, gentamicin and tobramycin to remove pregnancy as a contraindication for extended-interval dosing
Revisions to COVID-19 guidelines are noted within that section
Updated dosing for oseltamivir and vancomycin
Revised Pediatric Guidelines
Cleaned up internal references to Vancomycin and Aminoglycoside Dosing and Therapeutic Monitoring documents
Acyclovir dosing in BMI>30 changed to adjusted body weight
Added Aminoglycoside Dosing and Therapeutic Monitoring chapter
Updated Antimicrobial Dosing in Renal Insufficiency (Adults) chapter to align recommendations with BC Provincial Renal Agency document “Common Oral Antimicrobial Therapy Dosage Adjustments for Renal Function” dated Feb 2018